Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. [electronic resource]
- Circulation Oct 2012
- 2208-19 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1524-4539
10.1161/CIRCULATIONAHA.112.115592 doi
Acetanilides--therapeutic use Animals Cardiomegaly, Exercise-Induced Cardiomyopathy, Dilated--enzymology Consensus Sequence Disease Models, Animal Electrocardiography Enzyme Induction Heart Failure--enzymology Humans Hypertension--complications Immediate-Early Proteins--chemistry Ion Channel Gating--drug effects Mice Mice, Inbred C57BL Mice, Transgenic NAV1.5 Voltage-Gated Sodium Channel--chemistry Phosphatidylinositol 3-Kinases--physiology Phosphorylation Piperazines--therapeutic use Protein Interaction Mapping Protein Processing, Post-Translational Protein Serine-Threonine Kinases--chemistry Ranolazine Sodium Channel Blockers--pharmacology Tachycardia, Ventricular--enzymology Ventricular Remodeling--physiology